pirmenol has been researched along with Neurally Mediated Faint in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emi, S; Ishimoto, T; Kageyama, N; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T | 1 |
1 other study(ies) available for pirmenol and Neurally Mediated Faint
| Article | Year |
|---|---|
A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.
Topics: Aged; Anti-Arrhythmia Agents; Humans; Male; Midodrine; Piperidines; Prostatic Hyperplasia; Syncope, Vasovagal; Tilt-Table Test; Vasoconstrictor Agents | 2004 |